Page 23 - 2015 April 3D 細胞培養新趨勢

Cell-in-a-Box®技術應用舉例

 學術研究：3D細胞培養、多種細胞共同培養、藥物研發、基於細胞的研究等
 生物科技/醫藥：幹細胞、疫苗、抗體、生物大分子藥物等細胞産品或産物的

生産
 醫療保健：癌症、糖尿病、心血管病、退行性疾病、傳染病、遺傳病等的治療

BIOTECHNOLOGY 3D Cell Culture

Protection, Compartmertateation,
HEALTHCARE PreFiltration, Storage

Successful clinical trials over 40 -Protection of sensitive cell lines
scientific publications inside bioreactors
-Cancer RESEARCH
-Stem cell therapy
-Metabolic disease Tools for Scientists
-Infection disease -New animal models
-Cardiovascular disease -Research kit for
-Transplantation encapsulation of cells
-Inherited disease

PROBIOTICS COSMETICS

Keeping probiotic Enabling the use of probiotics
bacteria intact and stem cell in cosmetics
-Probiotics for humans -Soap with
-Animal feed encapsulated .probiotic bacteria.

AGRICULTURAL ENVIRONMENTAL

New ideas for more efficient Innovative solution to
farming and -seed improvement environmental Problem
-Encapsulation of seeds -Clean up of oil spills

Cell in a box訂購資訊

品 號 品 名 說 明 包 裝

一個kit可做5次實驗;產生120各膠囊; 每個膠
SI-CIB001 Cell-in-a-Box Cell Encapsulation Kit 1 kit
囊約有4000~40000顆細胞

參考文獻

1.Löhr M, Hoffmeyer A, Kröger J, Freund M, Hain J, Holle A, Karle P, Knöfel WT, Liebe S, Müller P, Nizze H, Renner M, Saller RM,
Wagner T, Hauenstein K, Günzburg WH, Salmons B. Lancet. Microencapsulated cell-mediated treatment of inoperable pancreatic
carcinoma. (2001) May 19;357(9268):1591-2.
2.Stadlbauer, V., Stiegler, P.B., Schaffellner, S., Hauser, O., Halwachs, G., Iberer, F., Tscheliessnigg, K.H. and Lackner, C. (2006)
Morphological and functional characterization of a pancreatic beta-cell line microencapsulated in sodium cellulose
sulfate/poly(diallyldimethylammonium chloride). Xenotransplantation 13, 337-344.
3.Stiegler, P., Stadlbauer, V., Hackl, F., Iberer F., Lackner, C., Hauser, O., Schaffellner, S., Strunk, D., Tscheliessnigg, K.H. (2009)
Xenotransplantation of NaCS microencapsulated porcine islet cells in diabetic rats. Organ Biology, 16(1) : 104.
4.Salmons, B., Brandtner, E.M., Hettrich, K. Wagenknecht, W., Volkert, B., Fischer, S., Dangerfield, J.A. and Gunzburg,W.H. (2010)
Encapsulated cells to focus the metabolic activation of anti-cancer drugs. Current Opinion in Molecular Therapeutics 12(4):450-60.
5.Chua, A.J.S., Brandtner, E.M., Dangerfield, J.A., Salmons, B., Gunzburg, W.H. and Ng, M.L. (2010) A novel cell encapsulation mode
for delivery of therapeutic antibodies against West Nile Virus infections that maintains steady plasma antibody levels throughout
therapy. International Congress on Infectious Diseases (ICID): Abstract 24.010. doi:10.1016/jijid.2010.02.
6.Salmons, B., Dangerfield, J.A., Brandtner, E.M., Toa, P., Tan, W Jin and Gunzburg, W.H. (2010) A method for protecting therapeutic
cells and microenvironment containment in patients for gene and cell therapies: a clinically proven enabling cell encapsulation
technology. Human Gene Therapy 21 1476-1477.
7.Salmons, B. and Gunzburg, W.H. (2010) Therapeutic application of cell microencapsulation in cancer. Advances in Experimental
Medicine and biology 670, 92-103.

21 UNI-ONWARD